CD4 and neoplasm: We firstly tested immunologic markers of CD4+, CD8+, CD68+, FOXP3+, PD‐L1+, CD4+FOXP3+, CD4+FOXP3−, CD68+PD‐L1+, CD68+PD‐L1−, CD8+PD‐L1+, and CD8+PDL1− in the tumor core area, tumor‐associated stroma area, and total area before NAC.